US 12068729
Anti-factor XII/XIIa antibodies and uses thereof
granted A61PA61P7/02
Quick answer
US patent 12068729 (Anti-factor XII/XIIa antibodies and uses thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Aug 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Aug 20 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 31
- CPC classes
- A61P, A61P7/02